BASEL, Switzerland--(BUSINESS WIRE)--NUCLIDIUM today announced the presentation of pre-clinical and clinical translation data from three of the company’s precision oncology programs targeting ...
Basel, Switzerland / Munich, Germany, October 01, 2025 – NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results